Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRKAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DDHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA8DP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AZU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIOK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00636 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on